Cargando…
Pre-injury polypharmacy as a predictor of outcomes in trauma patients
BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249840/ https://www.ncbi.nlm.nih.gov/pubmed/22229132 http://dx.doi.org/10.4103/2229-5151.84793 |
_version_ | 1782220394333208576 |
---|---|
author | Evans, David C Gerlach, Anthony T Christy, Jonathan M Jarvis, Amy M Lindsey, David E Whitmill, Melissa L Eiferman, Daniel Murphy, Claire V Cook, Charles H Beery, Paul R Steinberg, Steven M Stawicki, Stanislaw PA |
author_facet | Evans, David C Gerlach, Anthony T Christy, Jonathan M Jarvis, Amy M Lindsey, David E Whitmill, Melissa L Eiferman, Daniel Murphy, Claire V Cook, Charles H Beery, Paul R Steinberg, Steven M Stawicki, Stanislaw PA |
author_sort | Evans, David C |
collection | PubMed |
description | BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact of polypharmacy on outcomes in trauma patients 45 years and older. MATERIALS AND METHODS: Patients of age ≥45 years were identified from a Level I trauma center institutional registry. Detailed review of patient records included the following variables: Home medications, comorbid conditions, injury severity score (ISS), Glasgow coma scale (GCS), morbidity, mortality, hospital length of stay (LOS), intensive care unit (ICU) LOS, functional outcome measures (FOM), and discharge destination. Polypharmacy was defined by the number of medications: 0–4 (minor), 5–9 (major), or ≥10 (severe). Age- and ISS-adjusted analysis of variance and multivariate analyses were performed for these groups. Comorbidity–polypharmacy score (CPS) was defined as the number of pre-admission medications plus comorbidities. Statistical significance was set at alpha = 0.05. RESULTS: A total of 323 patients were examined (mean age 62.3 years, 56.1% males, median ISS 9). Study patients were using an average of 4.74 pre-injury medications, with the number of medications per patient increasing from 3.39 for the 45–54 years age group to 5.68 for the 75+ year age group. Age- and ISS-adjusted mortality was similar in the three polypharmacy groups. In multivariate analysis only age and ISS were independently predictive of mortality. Increasing polypharmacy was associated with more comorbidities, lower arrival GCS, more complications, and lower FOM scores for self-feeding and expression-communication. In addition, hospital and ICU LOS were longer for patients with severe polypharmacy. Multivariate analysis shows age, female gender, total number of injuries, number of complications, and CPS are independently associated with discharge to a facility (all, P < 0.02). CONCLUSION: Over 40% of trauma patients 45 years and older were receiving 5 or more medications at the time of their injury. Although these patients do not appear to have higher mortality, they are at increased risk for complications, lower functional outcomes, and longer hospital and intensive care stays. CPS may be useful when quantifying the severity of associated comorbid conditions in the context of traumatic injury and warrants further investigation. |
format | Online Article Text |
id | pubmed-3249840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32498402012-01-06 Pre-injury polypharmacy as a predictor of outcomes in trauma patients Evans, David C Gerlach, Anthony T Christy, Jonathan M Jarvis, Amy M Lindsey, David E Whitmill, Melissa L Eiferman, Daniel Murphy, Claire V Cook, Charles H Beery, Paul R Steinberg, Steven M Stawicki, Stanislaw PA Int J Crit Illn Inj Sci Original Article BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact of polypharmacy on outcomes in trauma patients 45 years and older. MATERIALS AND METHODS: Patients of age ≥45 years were identified from a Level I trauma center institutional registry. Detailed review of patient records included the following variables: Home medications, comorbid conditions, injury severity score (ISS), Glasgow coma scale (GCS), morbidity, mortality, hospital length of stay (LOS), intensive care unit (ICU) LOS, functional outcome measures (FOM), and discharge destination. Polypharmacy was defined by the number of medications: 0–4 (minor), 5–9 (major), or ≥10 (severe). Age- and ISS-adjusted analysis of variance and multivariate analyses were performed for these groups. Comorbidity–polypharmacy score (CPS) was defined as the number of pre-admission medications plus comorbidities. Statistical significance was set at alpha = 0.05. RESULTS: A total of 323 patients were examined (mean age 62.3 years, 56.1% males, median ISS 9). Study patients were using an average of 4.74 pre-injury medications, with the number of medications per patient increasing from 3.39 for the 45–54 years age group to 5.68 for the 75+ year age group. Age- and ISS-adjusted mortality was similar in the three polypharmacy groups. In multivariate analysis only age and ISS were independently predictive of mortality. Increasing polypharmacy was associated with more comorbidities, lower arrival GCS, more complications, and lower FOM scores for self-feeding and expression-communication. In addition, hospital and ICU LOS were longer for patients with severe polypharmacy. Multivariate analysis shows age, female gender, total number of injuries, number of complications, and CPS are independently associated with discharge to a facility (all, P < 0.02). CONCLUSION: Over 40% of trauma patients 45 years and older were receiving 5 or more medications at the time of their injury. Although these patients do not appear to have higher mortality, they are at increased risk for complications, lower functional outcomes, and longer hospital and intensive care stays. CPS may be useful when quantifying the severity of associated comorbid conditions in the context of traumatic injury and warrants further investigation. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3249840/ /pubmed/22229132 http://dx.doi.org/10.4103/2229-5151.84793 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Evans, David C Gerlach, Anthony T Christy, Jonathan M Jarvis, Amy M Lindsey, David E Whitmill, Melissa L Eiferman, Daniel Murphy, Claire V Cook, Charles H Beery, Paul R Steinberg, Steven M Stawicki, Stanislaw PA Pre-injury polypharmacy as a predictor of outcomes in trauma patients |
title | Pre-injury polypharmacy as a predictor of outcomes in trauma patients |
title_full | Pre-injury polypharmacy as a predictor of outcomes in trauma patients |
title_fullStr | Pre-injury polypharmacy as a predictor of outcomes in trauma patients |
title_full_unstemmed | Pre-injury polypharmacy as a predictor of outcomes in trauma patients |
title_short | Pre-injury polypharmacy as a predictor of outcomes in trauma patients |
title_sort | pre-injury polypharmacy as a predictor of outcomes in trauma patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249840/ https://www.ncbi.nlm.nih.gov/pubmed/22229132 http://dx.doi.org/10.4103/2229-5151.84793 |
work_keys_str_mv | AT evansdavidc preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT gerlachanthonyt preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT christyjonathanm preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT jarvisamym preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT lindseydavide preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT whitmillmelissal preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT eifermandaniel preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT murphyclairev preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT cookcharlesh preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT beerypaulr preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT steinbergstevenm preinjurypolypharmacyasapredictorofoutcomesintraumapatients AT stawickistanislawpa preinjurypolypharmacyasapredictorofoutcomesintraumapatients |